Author

Yan Zheng

h-index 5 View on Semantic Scholar

We have 3 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Patterns of Esophageal Cancer Stage at Diagnosis: A Systematic Review of Registry-Based Data.

AIMS Stage at diagnosis is a key factor influencing survival in patients with esophageal cancer. This study aims to assess the distribution of esophageal cancer stage at diagnosis using registry data from multiple countries/regions. METHODS PubMed, Embase, CNKI, and WanFang Data were systematically searched, suppleme...

Lan-Wei Guo, Chen-Xin Zhu, Le Wang et al. · Journal of Evidence-Based Me... · 0 citations

Open access Aug 2026

P1.083. Sequential Versus Concurrent Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized, Controlled, Open-Label, Phase II Trial

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant chemotherapy combined with PD-1 inhibitors has application potential for locally advanced esophageal squamous cell carcinoma (ESCC), but there is no prospective evidence for the optimal timing of the dose (sequential vs. concurrent)....

Yan Zheng, Jiwei Wu, Ling-Di Zhao et al. · Diseases of the esophagus · 0 citations

Aug 2026

OA06-LBA01.4. A Multimodal Classifier to Stratify Response to Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on RCT-HCHTOG1909

The esophageal cancer multimodal immuno-chemotherapy classifier (EMIC), which effectively stratifies patients into two groups with distinct therapeutic responses: EMIC1 (predicted to benefit from combined immuno-chemotherapy) and EMIC2 (predicted to have equivalent outcomes with chemotherapy alone), providing a rationa...

Yan Zheng, Wen-Qun Xing, Ji Wang et al. · Diseases of the esophagus · 0 citations